Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors
Clinical trial NCT02900157 · COMPLETED
Trial details
- NCT number
- NCT02900157
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-09
- Primary completion
- 2020-01-23
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.